Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects

Randomized,Double-blind,Single-dosing,Crossover Study to Compare the Safety and Pharmacokinetic Characteristics of HD203 With Active Comparator

The purpose of this study is compare the safety and pharmacokinetic characteristics of HD203 liquid with those of etanercept (enbrel) prefilled injection after subcutaneous injection.

A randomized, double-blind, single-dosing, crossover study to compare the safety and pharmacokinetic characteristics of HD203 Liquid 25 mg with those of Enbrel Prefilled® injection 25 mg after subcutaneous injection.

Inclusion Criteria:

• 20 to 40 years of healthy volunteers
• Weight over 55kg
• Subject who signed on ICF

Exclusion Criteria:

• Subject who had been treated with Etanercept before